Microbiology of bone and joint infections in injecting drug abusers

Daniel C Allison1, Paul D Holtom, Michael J Patzakis

  • 1Department of Orthopaedic Surgery, Keck School of Medicine, University of Southern California, LAC + USC Medical Center, 1200 N State Street, GNH 3900, Los Angeles, CA 90033, USA.

Abstract

Insights

Bone and joint infections in injecting drug users are often caused by Staphylococcus aureus, with a significant rise in oxacillin-resistant strains. Empiric antibiotic therapy should be broad-spectrum to cover these common pathogens.

Area of Science:

  • Infectious Diseases
  • Orthopedics
  • Microbiology

Background:

  • Injecting drug abuse is associated with a high risk of osteomyelitis and septic arthritis.
  • Causative organisms and resistance patterns for these infections vary, impacting empiric treatment decisions.

Purpose of the Study:

  • To determine the spectrum of microorganisms responsible for bone and joint infections in patients with a history of injecting drug abuse.

Main Methods:

  • Retrospective review of 215 patients with injecting drug abuse and bone/joint infections (1998-2005).
  • Analysis of infection sites, including osteomyelitis and septic arthritis, with a focus on microbial pathogens.
  • Evaluation of pathogen prevalence, including Gram-positive bacteria, Gram-negative organisms, and anaerobes.

Main Results:

  • Staphylococcus aureus was the predominant pathogen (52%), followed by coagulase-negative Staphylococcus (20%).
  • Oxacillin-resistant Staphylococcus aureus (ORSA) rates increased significantly from 21% in 1998 to 73% in 2005.
  • Osteomyelitis cases showed a higher incidence of polymicrobial (46%), Gram-negative (24%), and anaerobic (19%) infections compared to septic arthritis.

Conclusions:

  • Findings indicate a need for broad-spectrum empiric antibiotic therapy for bone and joint infections in injecting drug users.
  • Vancomycin should be considered in empiric regimens due to the high prevalence of Staphylococcus aureus and increasing ORSA rates.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...